You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

ACT is a tool for identifying those with poorly controlled asthma and it comprises 5 questions that assess the frequency of shortness of breath and general asthma symptoms, use of rescue medications, the effect of asthma on daily functioning, and overall self-assessment of asthma control.1,2

References:

  1. Melosini, L., Dente, F.L., Bacci, E., Bartoli, M.L., Cianchetti, S., Costa, F., Franco, A.D., Malagrino, L., Novelli, F., Vagaggini, B. and Paggiaro, P. (2012). Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control. Journal of asthma, 49(3), pp.317-323.3.
  2. Al-Moamary, Mohamed Saad; Alhaider, Sami A.; Allehebi, Riyad; Idrees, Majdy M.; Zeitouni, Mohammed O.; Al Ghobain, Mohammed O.; Alanazi, Abdullah F.; Al-Harbi, Adel S.; Yousef, Abdullah A.; Alorainy, Hassan S.; Al-Hajjaj, Mohammed S.. The Saudi initiative for asthma (2024) update: Guidelines for the diagnosis and management of asthma in adults and children. Annals of Thoracic Medicine (j):10.4103.

GSK does not recommend, endorse or accept liability for sites controlled by a third party.

Trademarks are owned by or licensed to the GSK group of companies.

PM-SA-FPS-WCNT-240003 Date of Preparation: June 2025